GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (OTCPK:GNMLF) » Definitions » Cyclically Adjusted FCF per Share

GNMLF (Genomma Lab InternacionalB de CV) Cyclically Adjusted FCF per Share : $0.00 (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Genomma Lab InternacionalB de CV Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Genomma Lab InternacionalB de CV's adjusted free cash flow per share for the three months ended in Mar. 2025 was $. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.00 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Genomma Lab InternacionalB de CV's average Cyclically Adjusted FCF Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 28.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 26.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Genomma Lab InternacionalB de CV was 30.40% per year. The lowest was 16.40% per year. And the median was 26.35% per year.

As of today (2025-05-16), Genomma Lab InternacionalB de CV's current stock price is $1.09. Genomma Lab InternacionalB de CV's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was $0.00. Genomma Lab InternacionalB de CV's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Genomma Lab InternacionalB de CV was 43.80. The lowest was 7.70. And the median was 21.43.


Genomma Lab InternacionalB de CV Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Cyclically Adjusted FCF per Share Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.05 0.06 0.10 0.10

Genomma Lab InternacionalB de CV Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.10 0.09 0.10 -

Competitive Comparison of Genomma Lab InternacionalB de CV's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Cyclically Adjusted Price-to-FCF falls into.


;
;

Genomma Lab InternacionalB de CV Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genomma Lab InternacionalB de CV's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.013/*
=

Current CPI (Mar. 2025) = .

Genomma Lab InternacionalB de CV Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.017 99.382 0.000
201509 0.021 100.112 0.000
201512 -0.004 101.588 0.000
201603 0.040 102.573 0.000
201606 0.021 101.905 0.000
201609 0.007 103.084 0.000
201612 0.023 105.002 0.000
201703 0.026 108.063 0.000
201706 0.012 108.339 0.000
201709 -0.032 109.628 0.000
201712 0.045 112.114 0.000
201803 0.003 113.505 0.000
201806 0.004 113.373 0.000
201809 -0.008 115.130 0.000
201812 0.073 117.530 0.000
201903 0.002 118.050 0.000
201906 -0.006 117.848 0.000
201909 0.015 118.581 0.000
201912 0.039 120.854 0.000
202003 0.017 121.885 0.000
202006 -0.004 121.777 0.000
202009 0.008 123.341 0.000
202012 0.060 124.661 0.000
202103 -0.001 127.574 0.000
202106 -0.005 128.936 0.000
202109 0.019 130.742 0.000
202112 0.048 133.830 0.000
202203 0.047 137.082 0.000
202206 0.010 139.233 0.000
202209 0.016 142.116 0.000
202212 0.031 144.291 0.000
202303 0.013 146.472 0.000
202306 0.024 146.272 0.000
202309 0.034 148.446 0.000
202312 0.050 151.017 0.000
202403 -0.011 152.947 0.000
202406 0.023 153.551 0.000
202409 0.072 155.158 0.000
202412 0.056 155.158 0.000
202503 -0.013 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Genomma Lab InternacionalB de CV  (OTCPK:GNMLF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Genomma Lab InternacionalB de CV was 43.80. The lowest was 7.70. And the median was 21.43.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Genomma Lab InternacionalB de CV Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.